Author Information
Mazin Adnan Barry is a prominent figure in the field of Infectious Diseases, serving in the Division of Infectious Diseases at the Department of Internal Medicine, King Saud University in Riyadh, Saudi Arabia. His extensive work and research focus primarily on infectious diseases, with a particular emphasis on COVID-19 and its implications. Dr. Barry has contributed significantly to understanding various infectious disease dynamics in Saudi Arabia and beyond, enhancing healthcare strategies and disease management protocols.Research Contributions
Dr. Mazin Adnan Barry has made substantial contributions to the field of infectious diseases, with numerous publications addressing key challenges and developments in the management of infections. His research spans several critical areas, including the clinical outcomes and therapeutic effectiveness of Favipiravir in COVID-19 patients, the implications of emerging COVID-19 variants on vaccine effectiveness, and the impact of these variants on healthcare workers. In addition, Dr. Barry's work on the healthcare burden and resource utilization for patients with HIV in Saudi Arabia provides valuable insights into the healthcare system's response to infectious diseases. His studies on healthcare workers' awareness and stress related to COVID-19 further contribute to the body of knowledge aimed at improving healthcare delivery and worker resilience during pandemics.Aliases
Dr. Mazin Adnan Barry is known by several aliases, including Mazin A Barry, Mazin Barry, M. Barry, M Barry, and M. Barry. These variations are commonly used in academic and professional publications, reflecting his contributions under slightly different name formats.Publication and Citation Metrics
| Metric |
Value |
| Publication Count |
103 |
| Citation Count |
2331 |
| h-index |
23 |
